SecuritySVA / Sinovac Biotech Ltd. (P8696W104)
Institutional Owners32
Institutional Shares17,642,553
Institutional Value$ 130,340,000 USD

Institutional Stock Ownership and Shareholders

Sinovac Biotech Ltd. (NASDAQ:SVA) has 32 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,642,553 shares. Largest shareholders include SAIF Advisors Ltd, Orbimed Advisors Llc, Renaissance Technologies LLC, Neumann Advisory Hong Kong Ltd, GLG Partners LP, State Street Corp, Sapphire Star Partners LP, Deutsche Bank Ag\, California Public Employees Retirement System, and Yorktown Management & Research Co Inc.
Sinovac Biotech Ltd. (NASDAQ:SVA) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-13 13F-HR GROUP ONE TRADING, L.P. Call 0 1,500 0 11
2018-08-03 13F-HR SEI INVESTMENTS CO 0 1 0 0
2018-07-30 13F-HR SIMPLEX TRADING, LLC Call 65 29 -55.38 7 21 200.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 0 50,500 0 377
2018-08-14 13F-HR Invesco Ltd. 107,171 20,923 -80.48 923 156 -83.10
2018-08-14 13F-HR MORGAN STANLEY 2,280 7,684 237.02 20 57 185.00
2018-08-14 13F-HR Centaurus Financial, Inc. 12 0
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 0 10,195 0 76
2017-10-26 13F-HR Acrospire Investment Management LLC 5,030 0 -100.00 34 0 -100.00
2018-08-14 13F-HR GUGGENHEIM CAPITAL LLC 20,840 0 -100.00 179 0 -100.00
2018-08-14 13F-HR Financial Gravity Wealth, Inc. 135 460 240.74 1 3 200.00
2018-02-14 13F-HR GLG Partners LP 758,859 271,072 -64.28 5,342 2,136 -60.01
2018-07-12 13F-HR Neumann Advisory Hong Kong Ltd 402,844 402,844 0.00 3,469 3,005 -13.38
2018-08-07 13F-HR SG Americas Securities, LLC 24,021 24,021 0.00 207 179 -13.53
2018-05-04 13F-HR Financial Gravity Companies, Inc. 10,546 135 -98.72 87 1 -98.85
2018-07-30 13F-HR SIMPLEX TRADING, LLC Put 0 10 0 7
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 27,717 27,717 0.00 238 206 -13.45
2018-08-14 13F-HR STATE STREET CORP 136,169 134,123 -1.50 1,172 1,001 -14.59
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 18,302 0 -100.00 158 0 -100.00
2018-08-14 13F-HR DLD Asset Management, LP 10,000 0 -100.00 86 0 -100.00
2018-08-08 13F-HR Spark Investment Management LLC 66,100 39,600 -40.09 569 295 -48.15
2018-08-06 13F-HR Navellier & Associates Inc 0 31,865 0 238
2018-08-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 10,000 0 -100.00 86 0 -100.00
2018-08-14 13F-HR/A CITADEL ADVISORS LLC Call 28,500 19,600 -31.23 245 146 -40.41
2018-08-14 13F-HR UBS Group AG 7,616 5,657 -25.72 66 42 -36.36
2018-08-08 13F-HR Sapphire Star Partners LP 96,992 723
2018-08-13 13F-HR Renaissance Technologies LLC 2,639,500 22,726
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 46,685 36,996 -20.75 402 276 -31.34
2017-10-18 13F-HR SAIF Advisors Ltd 10,780,820 10,780,820 0.00 72,771 76,005 4.44
2018-08-07 13F-HR IFP Advisors, Inc 2,000 1,000 -50.00 17 7 -58.82
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 20 0 -100.00 0 0
2018-08-14 13F-HR BARCLAYS PLC 22,300 11,100 -50.22 192 83 -56.77
2018-08-10 13F-HR Yorktown Management & Research Co Inc 64,645 482
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 48,400 40,700 -15.91 417 304 -27.10
2018-08-14 13F-HR ORBIMED ADVISORS LLC 2,839,500 2,839,500 0.00 24,448 21,183 -13.35
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 1,250 1,250 0.00 11 9 -18.18
2018-07-31 13F-HR CWM, LLC 500 500 0.00 4 4 0.00
2018-08-13 13F-HR PIONEER INVESTMENT MANAGEMENT INC 8,300 8,300 0.00 71 62 -12.68
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 92,127 70,064 -23.95 793 523 -34.05
2018-08-14 13F-HR DEUTSCHE BANK AG\ 178,466 73,337 -58.91 1,536 547 -64.39
2018-08-13 13F-HR GROUP ONE TRADING, L.P. 1,432 412 -71.23 12 3 -75.00
2018-07-27 13F-HR Eqis Capital Management, Inc. 158,993 41,828 -73.69 1,369 312 -77.21

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Week In Review: Suzhou Innovent Files For HK IPO - $500 Million Raise Rumored

2018-07-08 seekingalpha
Innovent Biologics of Suzhou has filed to IPO on the Hong Kong Exchange under its new rules for pre-revenue biopharmas. The company plans to raise as much as $500 million, according to media reports, at a valuation of over $1 billion. Founded in 2011, Innovent has developed a pipeline of 17 biologic drugs with an emphasis on oncology. In 2015, the company formed a historic partnership with Lilly (NYSE: LLY) worth up to $1 billion plus. (16-0)

10 Little-Known Stocks That Could Be Huge | InvestorPlace

2018-05-18 investorplace
The 10-year U.S. Treasury has crossed the rubicon. It is now flashing a yield that is over the 3% mark. What befalls the economy when that happens? Recession? Correction? A grinding bear market? (6-2)

BRIEF-Sinovac Resumes Production And Operation At Its Beijing's Quality Assurance Department

2018-04-23 reuters
* SINOVAC BIOTECH LTD - HEPATITIS A VACCINE AND SEASONAL FLU VACCINE PRODUCTION HAS RESUMED AT SHANGDI MANUFACTURING FACILITY OF UNIT (5-1)

10 Healthcare Stocks to Stave Off the Market Flu

2018-04-06 investorplace
While the markets run up and down because tech stocks are doing one thing or another, or retailers struggle to improve same-store sales, there isn’t much debate about the future of the healthcare sector. (173-1)

BRIEF-Sinovac Enters Into Amendment To Amalgamation Agreement For Going-Private Transaction

2018-03-27 reuters
* SINOVAC BIOTECH LTD - AMENDMENT EXTENDS TERMINATION DATE TO APRIL 26, 2018 FOR THE AMALGAMATION AGREEMENT DATED AS OF JUNE 26, 2017 Source text for Eikon: Further company coverage: ([email protected]) (5-1)

CUSIP: P8696W104